Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million
27/02/2026 07:57
Feb 27 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX: HY LOSS ATTRIBUTABLE A$33.2 MILLION REVENUE FROM ORDINARY ACTIVITIES FOR HY A$16.5 MILLION Further company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million
Australia's Botanix Pharmaceuticals slumps to 3-year low on discounted placement